NCT07810049Completed
Synchronous Bilateral Talc Pleurodesis
Synchronous Bilateral Talc Pleurodesis for Malignant Bilateral Pleural Effusions
Source: ClinicalTrials.gov · Last updated 9 Sept 2026
Brief summary (registry, in English)
Investigate feasibility of synchronous bilateral talc pleurodesis for malignant bilateral pleural effusions
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 31 (actual)
- First submitted
- 15 Jan 2026
- Start date
- Jan 1998
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- European Institute of Oncology
- Diseases
- Lung cancer
- NCT number
- NCT07810049
What you commit to
- Study type: Observational
- Participants enrolled: 31
- From Jan 1998 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Other type of surgery
Other illness
- Other type of diagnosis (e.g. viral disease)
Other
- Lack of consent to research
Who the study is looking for
- Age ≥ 18 year-old
- Patients undergoing synchronous bilateral talc pleurodesis
- Diagnosis of malignant bilateral pleural effusions
- Surgical resection between 1998 and September 2025
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituto Europeo di Oncologia Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.